Literature DB >> 17996249

Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning.

Thomas Tiller1, Eric Meffre, Sergey Yurasov, Makoto Tsuiji, Michel C Nussenzweig, Hedda Wardemann.   

Abstract

We have developed an efficient strategy that combines immunoglobulin (Ig) gene repertoire analysis and Ig reactivity profiling at the single cell level. Based on surface marker expression individual cells at different stages of human B cell development are isolated by fluorescence-activated cell sorting. For each cell Ig heavy and corresponding Ig light chain gene transcripts are amplified by nested RT-PCR and cloned into eukaryotic expression vectors to produce monoclonal human antibodies of the same specificity in vitro. All reactions are performed in 96-well plates and allow cloning of large numbers of Ig genes. The recombinant antibodies are tested for reactivity with diverse self- and non-self antigens and the reactivity profile can be directly linked to the complete Ig heavy and Ig light chain gene sequence information that is obtained as part of the cloning strategy. In summary, our method to clone and express human monoclonal antibodies is unbiased, highly efficient, requires only small cell numbers and the recombinant antibodies allow direct conclusions on the frequency of specific human B cells in a diverse repertoire.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996249      PMCID: PMC2243222          DOI: 10.1016/j.jim.2007.09.017

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  45 in total

1.  Contribution of receptor editing to the antibody repertoire.

Authors:  R Casellas; T A Shih; M Kleinewietfeld; J Rakonjac; D Nemazee; K Rajewsky; M C Nussenzweig
Journal:  Science       Date:  2001-02-23       Impact factor: 47.728

2.  Predominant autoantibody production by early human B cell precursors.

Authors:  Hedda Wardemann; Sergey Yurasov; Anne Schaefer; James W Young; Eric Meffre; Michel C Nussenzweig
Journal:  Science       Date:  2003-08-14       Impact factor: 47.728

3.  Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity.

Authors:  Maxime Hervé; Kai Xu; Yen-Shing Ng; Hedda Wardemann; Emilia Albesiano; Bradley T Messmer; Nicholas Chiorazzi; Eric Meffre
Journal:  J Clin Invest       Date:  2005-05-02       Impact factor: 14.808

4.  Monoclonal and recombinant antibodies, 30 years after ...

Authors:  Emmanuelle Laffly; Regis Sodoyer
Journal:  Hum Antibodies       Date:  2005

Review 5.  Use of immunoglobulin variable-region genes by normal subjects and patients with systemic lupus erythematosus.

Authors:  A Hansen; T Dörner; P E Lipsky
Journal:  Int Arch Allergy Immunol       Date:  2000-09       Impact factor: 2.749

6.  Human immunoglobulin variable region gene analysis by single cell RT-PCR.

Authors:  X Wang; B D Stollar
Journal:  J Immunol Methods       Date:  2000-10-20       Impact factor: 2.303

7.  Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies.

Authors:  Eric Meffre; Anne Schaefer; Hedda Wardemann; Patrick Wilson; Eric Davis; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2003-12-29       Impact factor: 14.307

8.  Human autoantibody silencing by immunoglobulin light chains.

Authors:  Hedda Wardemann; Johanna Hammersen; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2004-07-19       Impact factor: 14.307

9.  CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance.

Authors:  Maxime Hervé; Isabelle Isnardi; Yen-shing Ng; James B Bussel; Hans D Ochs; Charlotte Cunningham-Rundles; Eric Meffre
Journal:  J Exp Med       Date:  2007-06-11       Impact factor: 14.307

10.  An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus.

Authors:  Elisabetta Traggiai; Stephan Becker; Kanta Subbarao; Larissa Kolesnikova; Yasushi Uematsu; Maria Rita Gismondo; Brian R Murphy; Rino Rappuoli; Antonio Lanzavecchia
Journal:  Nat Med       Date:  2004-07-11       Impact factor: 53.440

View more
  491 in total

1.  Enhanced HIV-1 neutralization by antibody heteroligation.

Authors:  Hugo Mouquet; Malte Warncke; Johannes F Scheid; Michael S Seaman; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-04       Impact factor: 11.205

2.  A rapid and quantitative method for the evaluation of V gene usage, specificities and the clonal size of B cell repertoires.

Authors:  A M Vale; J B Foote; A Granato; Y Zhuang; R M S Pereira; U G Lopes; M Bellio; P D Burrows; H W Schroeder; A Nobrega
Journal:  J Immunol Methods       Date:  2011-12-28       Impact factor: 2.303

3.  Very few substitutions in a germ line antibody are required to initiate significant domain exchange.

Authors:  Michael Huber; Khoa M Le; Katie J Doores; Zara Fulton; Robyn L Stanfield; Ian A Wilson; Dennis R Burton
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

4.  Antibody 2G12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the HIV-1 glycan shield if domain exchanged.

Authors:  Katie J Doores; Zara Fulton; Michael Huber; Ian A Wilson; Dennis R Burton
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

Review 5.  Accessing the human repertoire for broadly neutralizing HIV antibodies.

Authors:  Philip W Hammond
Journal:  MAbs       Date:  2010 Mar-Apr       Impact factor: 5.857

6.  Strain-transcending Fc-dependent killing of Plasmodium falciparum by merozoite surface protein 2 allele-specific human antibodies.

Authors:  Janine Stubbs; Sope Olugbile; Balam Saidou; Jacques Simpore; Giampietro Corradin; Antonio Lanzavecchia
Journal:  Infect Immun       Date:  2010-12-28       Impact factor: 3.441

7.  Particulate Array of Well-Ordered HIV Clade C Env Trimers Elicits Neutralizing Antibodies that Display a Unique V2 Cap Approach.

Authors:  Paola Martinez-Murillo; Karen Tran; Javier Guenaga; Gustaf Lindgren; Monika Àdori; Yu Feng; Ganesh E Phad; Néstor Vázquez Bernat; Shridhar Bale; Jidnyasa Ingale; Viktoriya Dubrovskaya; Sijy O'Dell; Lotta Pramanik; Mats Spångberg; Martin Corcoran; Karin Loré; John R Mascola; Richard T Wyatt; Gunilla B Karlsson Hedestam
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

8.  Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation.

Authors:  Eileen Goodwin; Morgan S A Gilman; Daniel Wrapp; Man Chen; Joan O Ngwuta; Syed M Moin; Patricia Bai; Arvind Sivasubramanian; Ruth I Connor; Peter F Wright; Barney S Graham; Jason S McLellan; Laura M Walker
Journal:  Immunity       Date:  2018-02-03       Impact factor: 31.745

9.  De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease.

Authors:  Hamid Mattoo; Vinay S Mahajan; Emanuel Della-Torre; Yurie Sekigami; Mollie Carruthers; Zachary S Wallace; Vikram Deshpande; John H Stone; Shiv Pillai
Journal:  J Allergy Clin Immunol       Date:  2014-05-06       Impact factor: 10.793

10.  Caspr2-reactive antibody cloned from a mother of an ASD child mediates an ASD-like phenotype in mice.

Authors:  L Brimberg; S Mader; V Jeganathan; R Berlin; T R Coleman; P K Gregersen; P T Huerta; B T Volpe; B Diamond
Journal:  Mol Psychiatry       Date:  2016-10-04       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.